JPH06211798A - Tetrahydroisoquinoline derivative and its production - Google Patents
Tetrahydroisoquinoline derivative and its productionInfo
- Publication number
- JPH06211798A JPH06211798A JP696193A JP696193A JPH06211798A JP H06211798 A JPH06211798 A JP H06211798A JP 696193 A JP696193 A JP 696193A JP 696193 A JP696193 A JP 696193A JP H06211798 A JPH06211798 A JP H06211798A
- Authority
- JP
- Japan
- Prior art keywords
- group
- derivative
- alkyl group
- linear
- branched alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は医農薬製造に有用な有機
中間体に関する。さらに詳しくは、新規なヒドロキシテ
トラヒドロイソキノリノン誘導体及びテトラヒドロイソ
キノリノン誘導体並びにそれらの製造方法に関する。FIELD OF THE INVENTION The present invention relates to an organic intermediate useful for the production of medicines and agricultural chemicals. More specifically, it relates to novel hydroxytetrahydroisoquinolinone derivatives and tetrahydroisoquinolinone derivatives, and methods for producing them.
【0002】[0002]
【従来の技術】テトラヒドロイソキノリン骨格はベンゾ
フェナントリジンアルカロイドに含まれ、抗癌作用、抗
ウイルス作用等さまざまな生理活性が知られている〔例
えばJ.Am.Chem.Soc.,1983,10
5,2873;J.Org.Chem.,1977,4
2,1111;ibid.,1978,43,286;
ibid.,1987,52,907;ibid.,1
987,52,5378;J.Chem.Soc.
(C),1970,2578;Tetrahedro
n,1977,33,331;EP−A−0 025
598等〕。しかし公知のテトラヒドロイソキノリン誘
導体は特定の置換基が特定の位置にあるもののみが知ら
れており本発明で見出したものは知られていない。2. Description of the Related Art Tetrahydroisoquinoline skeleton is contained in benzophenanthridine alkaloids and is known to have various physiological activities such as anticancer action and antiviral action [eg J. Am. Chem. Soc. , 1983, 10
5,2873; Org. Chem. , 1977, 4
2, 1111; ibid. , 1978, 43, 286;
ibid. , 1987, 52, 907; ibid. , 1
987, 52, 5378; Chem. Soc.
(C), 1970, 2578; Tetrahedro.
n, 1977, 33, 331; EP-A-0 025.
598 etc.]. However, among known tetrahydroisoquinoline derivatives, only those having a specific substituent at a specific position are known, and those found in the present invention are not known.
【0003】[0003]
【発明が解決しようとする課題】医薬、農薬として重要
な役割をはたす有機中間体である新規なヒドロキシテト
ラヒドロイソキノリノン誘導体及びテトラヒドロイソキ
ノリノン誘導体並びにその製造方法を提供するものであ
る。The present invention provides a novel hydroxytetrahydroisoquinolinone derivative and tetrahydroisoquinolinone derivative which are organic intermediates which play important roles as medicines and agricultural chemicals, and a method for producing the same.
【0004】[0004]
【課題を解決するための手段】本発明者らは、医農薬中
間体として重要な新規なテトラヒドロイソキノリノン誘
導体に付き鋭意研究を行い本発明を完成した。Means for Solving the Problems The present inventors have completed the present invention by earnestly researching a novel tetrahydroisoquinolinone derivative which is important as an intermediate for medical and agricultural chemicals.
【0005】すなわち、本発明は一般式[I]That is, the present invention has the general formula [I]
【0006】[0006]
【化4】 [Chemical 4]
【0007】(R1はC1〜C6の直鎖または分岐したア
ルキル基を表し、R2は水素原子、C1〜C6の直鎖また
は分岐したアルキル基、ハロゲン原子を表す。)で表さ
れるヒドロキシテトラヒドロイソキノリノン誘導体及び
一般式[II](R 1 represents a C 1 to C 6 linear or branched alkyl group, and R 2 represents a hydrogen atom, a C 1 to C 6 linear or branched alkyl group, or a halogen atom). Hydroxytetrahydroisoquinolinone derivative represented and general formula [II]
【0008】[0008]
【化5】 [Chemical 5]
【0009】(R1、R2は前記と同様であり、R3はフ
ェニル基、C1〜C6の低級アルキル基、ハロゲン原子で
置換されたフェニル基、窒素,酸素,硫黄を単独もしく
は同時に含む5〜6員環複素環芳香族基で置換されたフ
ェニル基或いは窒素,酸素,硫黄を単独もしくは同時に
含む5〜6員環複素環芳香族基を表す。)で表されるテ
トラヒドロイソキノリノン誘導体、及びそれらの製造方
法を提供するものである。以下、本発明を詳細に説明す
る。(R 1 and R 2 are the same as above, and R 3 is a phenyl group, a C 1 -C 6 lower alkyl group, a phenyl group substituted with a halogen atom, nitrogen, oxygen and sulfur, either alone or at the same time. A tetrahydroisoquinolinone represented by a phenyl group substituted with a 5- or 6-membered heterocyclic aromatic group or a 5- or 6-membered heterocyclic aromatic group containing nitrogen, oxygen, or sulfur alone or simultaneously. A derivative and a method for producing the same are provided. Hereinafter, the present invention will be described in detail.
【0010】本発明化合物を具体的に説明すると、一般
式[I]で表されるヒドロキシイソキノリノン誘導体に
おけるR1としてはメチル、エチル、プロピル、イソプ
ロピル、ブチル、イソブチル、sec−ブチル、ter
t−ブチル、ペンチル、イソペンチル、ネオペンチル、
tert−ペンチル等のC1〜C6の直鎖または分岐アル
キル基を挙げることができる。好ましくは、メチル、エ
チルである。R2としては水素原子、メチル、エチル、
プロピル、イソプロピル、ブチル、イソブチル、sec
−ブチル、tert−ブチル、ペンチル、イソペンチ
ル、ネオペンチル、tert−ペンチル等のC1〜C6の
直鎖または分岐アルキル基、塩素、臭素、フッ素等のハ
ロゲン原子を挙げることができる。The compound of the present invention will be described in detail. R 1 in the hydroxyisoquinolinone derivative represented by the general formula [I] is methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl or ter.
t-butyl, pentyl, isopentyl, neopentyl,
Mention may be made of C 1 -C 6 linear or branched alkyl groups such as tert-pentyl. Preferred are methyl and ethyl. R 2 is a hydrogen atom, methyl, ethyl,
Propyl, isopropyl, butyl, isobutyl, sec
Examples thereof include C 1 to C 6 linear or branched alkyl groups such as -butyl, tert-butyl, pentyl, isopentyl, neopentyl, and tert-pentyl, and halogen atoms such as chlorine, bromine, and fluorine.
【0011】一般式[II]で表されるテトラヒドロイ
ソキノリノン誘導体におけるR1及びR2は前記と同様で
あり、R3としてはフェニル基、メチル、エチル、プロ
ピル、イソプロピル、ブチル、イソブチル、sec−ブ
チル、tert−ブチル、ペンチル、イソペンチル、ネ
オペンチル、tert−ペンチル等のC1〜C6の直鎖ま
たは分岐アルキル基或いは塩素、臭素、フッ素等のハロ
ゲン原子或いはフリル基、フェニル基、ピロリル基、チ
エニル基、オキサゾリル基、チアゾリル基、イミダゾリ
ル基、ピラゾリル基、イソオキサゾリル基、イソチアゾ
リル基、ピリジル基等の芳香族置換基で置換されたフェ
ニル基;或いはフリル基、フェニル基、ピロリル基、チ
エニル基、オキサゾリル基、チアゾリル基、イミダゾリ
ル基、ピラゾリル基、イソオキサゾリル基、イソチアゾ
リル基、ピリジル基等の芳香族置換基で置換されたフリ
ル基、ピロリル基、チエニル基、オキサゾリル基、チア
ゾリル基、イミダゾリル基、ピラゾリル基、イソオキサ
ゾリル基、イソチアゾリル基、ピリジル基等の複素芳香
族置換基を挙げることができる。R 1 and R 2 in the tetrahydroisoquinolinone derivative represented by the general formula [II] are the same as above, and R 3 is phenyl group, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec. - butyl, tert- butyl, pentyl, isopentyl, neopentyl, tert- linear or branched alkyl group or a chlorine C 1 -C 6 of pentyl, bromine, halogen atom or a furyl group such as fluorine, a phenyl group, pyrrolyl group, A phenyl group substituted with an aromatic substituent such as a thienyl group, an oxazolyl group, a thiazolyl group, an imidazolyl group, a pyrazolyl group, an isoxazolyl group, an isothiazolyl group, a pyridyl group; or a furyl group, a phenyl group, a pyrrolyl group, a thienyl group, an oxazolyl group. Group, thiazolyl group, imidazolyl group, pyrazoly Group, isoxazolyl group, isothiazolyl group, furyl group substituted with an aromatic substituent such as pyridyl group, pyrrolyl group, thienyl group, oxazolyl group, thiazolyl group, imidazolyl group, pyrazolyl group, isoxazolyl group, isothiazolyl group, pyridyl group, etc. The heteroaromatic substituents can be mentioned.
【0012】R3CH2O基の置換位置として、5位、6
位、7位、8位を挙げることができる。As the substitution position of the R 3 CH 2 O group, 5-position, 6-position
The seventh, the eighth and the eighth can be mentioned.
【0013】本発明はまた一般式[I]で表されるヒド
ロキシテトラヒドロイソキノリノン誘導体及び一般式
[II]で表されるテトラヒドロイソキノリノン誘導体
の製造方法も提供するものである。The present invention also provides a method for producing a hydroxytetrahydroisoquinolinone derivative represented by the general formula [I] and a tetrahydroisoquinolinone derivative represented by the general formula [II].
【0014】本発明化合物の製法を具体的に説明する。The method for producing the compound of the present invention will be specifically described.
【0015】一般式[I]で表されるヒドロキシテトラ
ヒドロイソキノリノン誘導体は一般式[III]The hydroxytetrahydroisoquinolinone derivative represented by the general formula [I] is represented by the general formula [III]
【0016】[0016]
【化6】 [Chemical 6]
【0017】(R1、R2は前記と同様であり、R4はC1
〜C4の直鎖または分岐したアルキル基を表す。)で表
されるイソキノリノン誘導体を臭化水素酸,塩酸,硫酸
等の鉱酸、酢酸,トリフルオロ酢酸等の有機酸或いは塩
化アルミニウム,三臭化硼素等のハロゲン化金属等脱ア
ルキル化剤存在下、水,酢酸,アルコール等の溶媒存在
下或いは溶媒非存在下で反応することにより製造でき
る。(R 1 and R 2 are the same as above, and R 4 is C 1
~C represents a linear or branched alkyl group of 4. ) In the presence of a mineral acid such as hydrobromic acid, hydrochloric acid or sulfuric acid, an organic acid such as acetic acid or trifluoroacetic acid, or a dealkylating agent such as a metal halide such as aluminum chloride or boron tribromide. It can be produced by reacting in the presence or absence of a solvent such as water, acetic acid or alcohol.
【0018】反応温度は0℃〜200℃、好ましくは5
0℃〜150℃、反応時間は5分から200時間、好ま
しくは30分から60時間であり、反応に用いられる試
薬の量は、式[III]で示される化合物1当量に対し
て脱アルキル下剤0.1当量から100当量である。The reaction temperature is 0 ° C to 200 ° C, preferably 5 ° C.
The reaction time is 5 minutes to 200 hours, preferably 30 minutes to 60 hours, and the amount of the reagent used in the reaction is 0.degree. It is 1 to 100 equivalents.
【0019】反応に用いられる溶媒としては、メタノー
ル、エタノール、プロパノール、イソプロパノール等の
アルコール類、酢酸、トリフルオロ酢酸等の有機酸、エ
ーテル、テトラハイドロフラン、ジオキサン等のエーテ
ル類をを用いることができる。As the solvent used in the reaction, alcohols such as methanol, ethanol, propanol and isopropanol, organic acids such as acetic acid and trifluoroacetic acid, ethers such as ether, tetrahydrofuran and dioxane can be used. .
【0020】一般式[I]で表されるヒドロキシテトラ
ヒドロイソキノリノン誘導体と一般式[IV] R5CH2X [IV] (但し、R5はフェニル基、C1〜C6の低級アルキル
基、ハロゲン原子で置換されたフェニル基、窒素,酸
素,硫黄を単独もしくは同時に含む5〜6員環複素環芳
香族基で置換されたフェニル基或いは窒素,酸素,硫黄
を単独もしくは同時に含む5〜6員環複素環芳香族基を
表し、Xはハロゲン原子を表す。)で表されるハロゲン
化合物を溶媒非存在下或いは存在下、塩基存在のもとに
反応させ一般式[II]で表されるテトラヒドロイソキ
ノリノン誘導体を製造できる。一般式[IV]で表され
るハロゲン化合物のR5としては前記一般式[II]の
R3と同様なものを挙げることが出来る。ハロゲン原子
としては塩素、臭素、沃素等を挙げることができる。A hydroxytetrahydroisoquinolinone derivative represented by the general formula [I] and a general formula [IV] R 5 CH 2 X [IV] (wherein R 5 is a phenyl group, a C 1 -C 6 lower alkyl group) A phenyl group substituted with a halogen atom, a phenyl group substituted with a 5- or 6-membered heterocyclic aromatic group containing nitrogen, oxygen, or sulfur alone or simultaneously or 5-6 containing nitrogen, oxygen, or sulfur alone or simultaneously A membered ring heterocyclic aromatic group, and X represents a halogen atom.) Is represented by the general formula [II] by reacting a halogen compound represented by the formula (II) with or without a solvent in the presence of a base. A tetrahydroisoquinolinone derivative can be produced. As R 5 of the halogen compound represented by the general formula [IV], those similar to R 3 of the general formula [II] can be mentioned. Examples of the halogen atom include chlorine, bromine, iodine and the like.
【0021】反応に用いられる好ましい塩基としては炭
酸ナトリウム、炭酸カリウム、水酸化ナトリウム、水酸
化カリウム等のアルカリ金属炭酸塩及びアルカリ金属水
酸化物を挙げることができる。Preferred bases used in the reaction include alkali metal carbonates and alkali metal hydroxides such as sodium carbonate, potassium carbonate, sodium hydroxide and potassium hydroxide.
【0022】反応に用いられる溶媒の好ましい例として
はアセトン、メチルエチルケトン等のケトン類、ベンゼ
ン、トルエン、キシレン等の芳香族炭化水素類、ジエチ
ルエーテル、テトラヒドロフラン、ジオキサン等のエー
テル類、ジクロロメタン、クロロホルム、クロロベンゼ
ン等のハロゲン化炭化水素類、ピリジン、トリエチルア
ミン、N,N−ジメチルアニリン等の第三級アミン、ア
セトニトリル、N,N−ジメチルホルムアミド、ジメチ
ルスルホキシド、1,3−ジメチル−2−イミダゾリジ
ノン、リン酸ヘキサメチルトリアミド等の極性溶媒等を
挙げることができる。Preferred examples of the solvent used in the reaction include ketones such as acetone and methyl ethyl ketone, aromatic hydrocarbons such as benzene, toluene and xylene, ethers such as diethyl ether, tetrahydrofuran and dioxane, dichloromethane, chloroform and chlorobenzene. Halogenated hydrocarbons such as pyridine, triethylamine, tertiary amines such as N, N-dimethylaniline, acetonitrile, N, N-dimethylformamide, dimethyl sulfoxide, 1,3-dimethyl-2-imidazolidinone, phosphorus Examples thereof include polar solvents such as acid hexamethyltriamide.
【0023】反応温度は0℃〜200℃、好ましくは5
0℃〜150℃、反応時間は5分から200時間、好ま
しくは30分から60時間であり、反応に用いられる試
薬の量は、一般式[I]で示される化合物1当量に対し
て一般式[IV]で示される化合物は0.1当量から1
0当量、塩基は0.1当量から20当量である。The reaction temperature is 0 ° C to 200 ° C, preferably 5 ° C.
The reaction time is 5 minutes to 200 hours, preferably 30 minutes to 60 hours, and the amount of the reagent used in the reaction is 1 to 1 equivalent of the compound represented by the general formula [I]. ] The compound shown by] is 0.1 equivalent to 1
0 equivalent and the base are 0.1 to 20 equivalents.
【0024】[0024]
【発明の効果】本発明により、医農薬中間体としてして
有用性の高い化合物及びその製造法を提供することがで
きた。Industrial Applicability According to the present invention, it is possible to provide a compound which is highly useful as an intermediate for medicines and agricultural chemicals and a method for producing the same.
【0025】[0025]
【実施例】以下、本発明を実施例により具体的に説明す
るが、本発明はこれらの実施例のみに限定されるもので
はない。EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.
【0026】実施例1[3−(4−tert−ブチルフ
ェニル)−7−ヒドロキシ−2−メチル−1,2,3,
4−テトラヒドロイソキノリン−1−オン(化合物番号
1)の製造(1)] 3−(4−tert−ブチルフェニル)−7−メトキシ
−2−メチル−1,2,3,4−テトラヒドロキノリン
−1−オン;10.82gを酢酸10mlに溶解した溶
液に47%臭化水素酸水溶液30mlを加え、120℃
で一昼夜反応した。反応終了後、反応混合物より溶媒を
減圧溜去し、残渣を1N水酸化ナトリウム水溶液に溶解
しジエチルエーテルで洗浄した。水層に塩酸を加えて中
和し、酢酸エチルで抽出した(200ml×3)。集め
た有機層を飽和食塩水で洗浄後、無水硫酸マグネシウム
で乾燥した。溶媒を減圧下溜去し、3−(4−tert
−ブチルフェニル)−7−ヒドロキシ−2−メチル−
1,2,3,4−テトラヒドロキノリン−1−オン;
9.15gを得た(収率86%)。Example 1 [3- (4-tert-butylphenyl) -7-hydroxy-2-methyl-1,2,3,3]
Production of 4-tetrahydroisoquinolin-1-one (Compound No. 1) (1)] 3- (4-tert-Butylphenyl) -7-methoxy-2-methyl-1,2,3,4-tetrahydroquinoline-1 -ON: To a solution of 10.82 g dissolved in 10 ml of acetic acid was added 30 ml of 47% hydrobromic acid aqueous solution, and the temperature was 120 ° C.
I reacted all day and night. After completion of the reaction, the solvent was distilled off from the reaction mixture under reduced pressure, the residue was dissolved in a 1N sodium hydroxide aqueous solution and washed with diethyl ether. Hydrochloric acid was added to the aqueous layer to neutralize it, and the mixture was extracted with ethyl acetate (200 ml × 3). The collected organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 3- (4-tert.
-Butylphenyl) -7-hydroxy-2-methyl-
1,2,3,4-tetrahydroquinolin-1-one;
9.15 g was obtained (yield 86%).
【0027】1 H−NMR(δppm /CDCl3,300MHz) 8.19(1H,s),7.38(1H,s),7.26(2H,d,J=7.5),6.88 〜7.04
(4H,m),4.73(1H,dd,J=6.7,2.5),3.58(1H,dd,J=15.8,6.
7),3.98(1H,dd,J=15.8,2.5),1.27(9H,s) IR(cm-1/KBr) 3310,2960,1640,1600,1490,1275,1230 m.p. 247〜248℃ 元素分析(%) C20H23NO2 として 実測値 C;77.80,H;7.38,N;4.58 計算値 C;77.64,H;7.49,N;4.53 実施例2[3−(4−tert−ブチルフェニル)−7
−ヒドロキシ−2−メチル−1,2,3,4−テトラヒ
ドロイソキノリン−1−オン(化合物番号1)の製造
(2)] 3−(4−tert−ブチルフェニル)−7−メトキシ
−2−メチル−1,2,3,4−テトラヒドロキノリン
−1−オン;1.01gをベンゼン10mlに溶解した
溶液に塩化アルミニウム;0.75gを加え、加熱還流
下、一昼夜反応した。反応終了後、反応混合物に1N塩
酸50mlを加え、酢酸エチルで抽出した(100ml
×3)。集めた有機層を飽和食塩水で洗浄後、無水硫酸
マグネシウムで乾燥した。溶媒を減圧下溜去し、3−
(4−tert−ブチルフェニル)−7−ヒドロキシ−
2−メチル−1,2,3,4−テトラヒドロキノリン−
1−オン;0.87gを得た(収率90%)。 1 H-NMR (δppm / CDCl 3 , 300 MHz) 8.19 (1H, s), 7.38 (1H, s), 7.26 (2H, d, J = 7.5), 6.88 to 7.04
(4H, m), 4.73 (1H, dd, J = 6.7,2.5), 3.58 (1H, dd, J = 15.8,6.
7), 3.98 (1H, dd, J = 15.8,2.5), 1.27 (9H, s) IR (cm −1 / KBr) 3310,2960,1640,1600,1490,1275,1230 m. p. From 247 to 248 ° C. Elemental analysis (%) Found C as C 20 H 23 NO 2; 77.80 , H; 7.38, N; 4.58 Calculated C; 77.64, H; 7.49, N; 4.53 Example 2 [3- (4 -Tert-butylphenyl) -7
-Hydroxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-one (Compound No. 1) (2)] 3- (4-tert-Butylphenyl) -7-methoxy-2-methyl Aluminum chloride (0.75 g) was added to a solution prepared by dissolving 1.01 g of -1,2,3,4-tetrahydroquinolin-1-one (1.01 g) in benzene (10 ml), and the mixture was reacted overnight with heating under reflux. After completion of the reaction, 50 ml of 1N hydrochloric acid was added to the reaction mixture and extracted with ethyl acetate (100 ml).
× 3). The collected organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 3-
(4-tert-butylphenyl) -7-hydroxy-
2-methyl-1,2,3,4-tetrahydroquinoline-
1-one; 0.87 g was obtained (yield 90%).
【0028】実施例3[3−(4−tert−ブチルフ
ェニル)−7−ヒドロキシ−2−メチル−1,2,3,
4−テトラヒドロイソキノリン−1−オン(化合物番号
1)の製造(3)] 3−(4−tert−ブチルフェニル)−7−メトキシ
−2−メチル−1,2,3,4−テトラヒドロキノリン
−1−オン;1.00gをベンゼン10mlに溶解し、
塩化アルミニウムに換えて三臭化硼素;1.62gを用
いて実施例2と同様の反応を行うことにより、3−(4
−tert−ブチルフェニル)−7−ヒドロキシ−2−
メチル−1,2,3,4−テトラヒドロキノリン−1−
オン;0.79gを得た(収率83%)。Example 3 [3- (4-tert-butylphenyl) -7-hydroxy-2-methyl-1,2,3,3]
Production of 4-tetrahydroisoquinolin-1-one (Compound No. 1) (3)] 3- (4-tert-Butylphenyl) -7-methoxy-2-methyl-1,2,3,4-tetrahydroquinoline-1 -ON; 1.00 g is dissolved in 10 ml of benzene,
By performing the same reaction as in Example 2 by using 1.62 g of boron tribromide in place of aluminum chloride, 3- (4
-Tert-butylphenyl) -7-hydroxy-2-
Methyl-1,2,3,4-tetrahydroquinoline-1-
On; 0.79 g was obtained (yield 83%).
【0029】実施例4[3−(4−tert−ブチルフ
ェニル)−7−ヒドロキシ−2−メチル−1,2,3,
4−テトラヒドロイソキノリン−1−オン(化合物番号
1)の製造(4)] 3−(4−tert−ブチルフェニル)−7−tert
−ブトキシ−2−メチル−1,2,3,4−テトラヒド
ロキノリン−1−オン;1.02gをトリフルオロ酢酸
10mlに溶解し、室温で一晩反応した。反応終了後、
反応混合物を減圧下乾固、残渣を1N水酸化ナトリウム
水溶液に溶解しジエチルエーテルで洗浄した。水層に塩
酸を加えて中和し、酢酸エチルで抽出した(100ml
×3)。集めた有機層を飽和食塩水で洗浄後、無水硫酸
マグネシウムで乾燥した。溶媒を減圧下溜去し、3−
(4−tert−ブチルフェニル)−7−ヒドロキシ−
2−メチル−1,2,3,4−テトラヒドロキノリン−
1−オン0.63gを得た(収率73%)。Example 4 [3- (4-tert-butylphenyl) -7-hydroxy-2-methyl-1,2,3,3]
Preparation of 4-tetrahydroisoquinolin-1-one (Compound No. 1) (4)] 3- (4-tert-Butylphenyl) -7-tert
-Butoxy-2-methyl-1,2,3,4-tetrahydroquinolin-1-one; 1.02 g was dissolved in 10 ml of trifluoroacetic acid and reacted overnight at room temperature. After the reaction,
The reaction mixture was dried under reduced pressure, the residue was dissolved in a 1N aqueous sodium hydroxide solution and washed with diethyl ether. Hydrochloric acid was added to the aqueous layer for neutralization, and the mixture was extracted with ethyl acetate (100 ml
× 3). The collected organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 3-
(4-tert-butylphenyl) -7-hydroxy-
2-methyl-1,2,3,4-tetrahydroquinoline-
0.63 g of 1-one was obtained (yield 73%).
【0030】実施例5[3−(4−tert−ブチルフ
ェニル)−7−(2−メチルベンジルオキシ)−2−メ
チル−1,2,3,4−テトラヒドロイソキノリン−1
−オン(化合物番号6)の製造] 3−(4−tert−ブチルフェニル)−7−ヒドロキ
シ−2−メチル−1,2,3,4−テトラヒドロイソキ
ノリン−1−オン;1.501gをアセトニトリル70
mlに溶解した溶液に2−メチルベンジルブロマイド;
918mgと炭酸カリウム;1.009gを加え、加熱
還流により16時間反応した。反応終了後、反応混合物
をジエチルエーテル中に注ぎ込み、この溶液を水で洗浄
した。有機層を飽和食塩水で洗浄後、無水硫酸マグネシ
ウムで乾燥した。溶媒を減圧下溜去し、残渣をシリカゲ
ルカラムクロマトグラフィー(ヘキサン/酢酸エチル=
4/1)で精製し、3−(4−tert−ブチルフェニ
ル)−7−(2−メチルベンジルオキシ)−2−メチル
−1,2,3,4−テトラヒドロキノリン−1−オン;
1.871gを得た(収率93%)。Example 5 [3- (4-tert-Butylphenyl) -7- (2-methylbenzyloxy) -2-methyl-1,2,3,4-tetrahydroisoquinoline-1
Preparation of 3-one (Compound No. 6)] 3- (4-tert-Butylphenyl) -7-hydroxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-one; 1.501 g of acetonitrile 70
2-methylbenzyl bromide in a solution dissolved in ml;
918 mg and potassium carbonate (1.009 g) were added, and the mixture was reacted by heating under reflux for 16 hours. After completion of the reaction, the reaction mixture was poured into diethyl ether and this solution was washed with water. The organic layer was washed with saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (hexane / ethyl acetate =
4/1), 3- (4-tert-butylphenyl) -7- (2-methylbenzyloxy) -2-methyl-1,2,3,4-tetrahydroquinolin-1-one;
1.871 g was obtained (yield 93%).
【0031】1 H−NMR(δppm /CDCl3,300MHz) 7.85(1H,d,J=2.4Hz),7.45(1H,d,J=7.2Hz),7.29(2H,d,J=
8.1Hz),7.25(3H,m),7.03(2H,d,J=8.2Hz),7.01(1H,dd,J=
8.4,2.4),6.95(1H,dd,J=8.4),5.11(1H,dd,J=15.9,3.0),
2.41(3H,s),1.29(9H,s) IR(cm-1/KBr) 粘稠油状物 元素分析(%) C28H33NOとして 実測値 C;83.93,H;8.60,N;3.38 計算値 C;84.17,H;8.32,N;3.51 実施例6〜13 表1に示す化合物番号2〜5及び8〜11のテトラヒド
ロイソキノリノン誘導体を実施例5の方法に従い製造し
た。得られた化合物の物性値を表2〜表6に示す。 1 H-NMR (δppm / CDCl 3 , 300 MHz) 7.85 (1H, d, J = 2.4Hz), 7.45 (1H, d, J = 7.2Hz), 7.29 (2H, d, J =
8.1Hz), 7.25 (3H, m), 7.03 (2H, d, J = 8.2Hz), 7.01 (1H, dd, J =
8.4,2.4), 6.95 (1H, dd, J = 8.4), 5.11 (1H, dd, J = 15.9,3.0),
2.41 (3H, s), 1.29 (9H, s) IR (cm -1 / KBr) Viscous oil Elemental analysis (%) Actual value as C 28 H 33 NO C; 83.93, H; 8.60, N; 3.38 Calculation Value C; 84.17, H; 8.32, N; 3.51 Examples 6 to 13 Tetrahydroisoquinolinone derivatives of compound numbers 2 to 5 and 8 to 11 shown in Table 1 were prepared according to the method of Example 5. Physical properties of the obtained compound are shown in Tables 2 to 6.
【0032】実施例14 表1に示す化合物番号7のテトラヒドロイソキノリノン
誘導体を実施例1の方法に従い製造した。得られた化合
物の物性値を表4に示す。Example 14 The tetrahydroisoquinolinone derivative of Compound No. 7 shown in Table 1 was produced according to the method of Example 1. Table 4 shows the physical properties of the obtained compound.
【0033】[0033]
【表1】 [Table 1]
【0034】[0034]
【表2】 [Table 2]
【0035】[0035]
【表3】 [Table 3]
【0036】[0036]
【表4】 [Table 4]
【0037】[0037]
【表5】 [Table 5]
【0038】[0038]
【表6】 [Table 6]
Claims (4)
し、R2は水素原子、C1〜C6の直鎖または分岐したア
ルキル基、ハロゲン原子を表す。)で表されるヒドロキ
シテトラヒドロイソキノリノン誘導体。1. A compound represented by the general formula [I]: (R 1 represents a C 1 to C 6 linear or branched alkyl group, and R 2 represents a hydrogen atom, a C 1 to C 6 linear or branched alkyl group, or a halogen atom.). Hydroxytetrahydroisoquinolinone derivative.
す。R2はC1〜C6の直鎖または分岐したアルキル基、
ハロゲン原子を表し、R3はフェニル基、C1〜C6の低
級アルキル基、ハロゲン原子で置換されたフェニル基、
窒素,酸素,硫黄を単独もしくは同時に含む5〜6員環
複素環芳香族基で置換されたフェニル基或いは窒素,酸
素,硫黄を単独もしくは同時に含む5〜6員環複素環芳
香族基を表す。)で表されるテトラヒドロイソキノリノ
ン誘導体。2. A compound represented by the general formula [II]: (R 1 represents a C 1 -C 6 linear or branched alkyl group. R 2 represents a C 1 -C 6 linear or branched alkyl group,
Represents a halogen atom, R 3 is a phenyl group, a C 1 to C 6 lower alkyl group, a phenyl group substituted with a halogen atom,
It represents a phenyl group substituted with a 5- or 6-membered heterocyclic aromatic group containing nitrogen, oxygen, or sulfur alone or simultaneously, or a 5- or 6-membered heterocyclic aromatic group containing nitrogen, oxygen, or sulfur alone or simultaneously. ) A tetrahydroisoquinolinone derivative represented by:
し、R2はC1〜C6の直鎖または分岐したアルキル基、
ハロゲン原子を表し、R4はC1〜C4の直鎖または分岐
したアルキル基を表す。)で表されるイソキノリノン誘
導体を鉱酸、ト有機酸或いはハロゲン化金属と反応させ
る請求項1記載のヒドロキシテトラヒドロイソキノリノ
ン誘導体の製造方法。3. A compound represented by the general formula [III]: (R 1 represents a C 1 to C 6 linear or branched alkyl group, R 2 represents a C 1 to C 6 linear or branched alkyl group,
It represents a halogen atom, and R 4 represents a C 1 to C 4 linear or branched alkyl group. The method for producing a hydroxytetrahydroisoquinolinone derivative according to claim 1, wherein the isoquinolinone derivative represented by (4) is reacted with a mineral acid, a triorganoic acid or a metal halide.
般式[IV] R5CH2X [IV] (但し、R5はフェニル基、C1〜C6の低級アルキル
基、ハロゲン原子で置換されたフェニル基、窒素,酸
素,硫黄を単独もしくは同時に含む5〜6員環複素環芳
香族基で置換されたフェニル基或いは窒素,酸素,硫黄
を単独もしくは同時に含む5〜6員環複素環芳香族基を
表し、Xはハロゲン原子を表す。)で表されるハロゲン
化合物を塩基存在下反応させる請求項2記載のテトラヒ
ドロイソキノリノン誘導体の製造方法。4. The isoquinolinone derivative according to claim 1 and the general formula [IV] R 5 CH 2 X [IV] (wherein R 5 is substituted with a phenyl group, a C 1 -C 6 lower alkyl group, or a halogen atom). A phenyl group, a phenyl group substituted with a 5- or 6-membered heterocyclic aromatic group containing nitrogen, oxygen, or sulfur alone or simultaneously, or a 5- or 6-membered heterocyclic aromatic group containing nitrogen, oxygen, or sulfur alone or simultaneously Group is represented and X represents a halogen atom.) The method for producing a tetrahydroisoquinolinone derivative according to claim 2, wherein the halogen compound represented by the formula (1) is reacted in the presence of a base.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP696193A JPH06211798A (en) | 1993-01-19 | 1993-01-19 | Tetrahydroisoquinoline derivative and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP696193A JPH06211798A (en) | 1993-01-19 | 1993-01-19 | Tetrahydroisoquinoline derivative and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06211798A true JPH06211798A (en) | 1994-08-02 |
Family
ID=11652817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP696193A Pending JPH06211798A (en) | 1993-01-19 | 1993-01-19 | Tetrahydroisoquinoline derivative and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06211798A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9708315B2 (en) | 2013-09-06 | 2017-07-18 | Janssen Pharmaceutica Nv | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors |
US9737533B2 (en) | 2009-05-12 | 2017-08-22 | Janssen Pharmaceuticals. Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US10106542B2 (en) | 2013-06-04 | 2018-10-23 | Janssen Pharmaceutica Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US11071729B2 (en) | 2007-09-14 | 2021-07-27 | Addex Pharmaceuticals S.A. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones |
-
1993
- 1993-01-19 JP JP696193A patent/JPH06211798A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11071729B2 (en) | 2007-09-14 | 2021-07-27 | Addex Pharmaceuticals S.A. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones |
US9737533B2 (en) | 2009-05-12 | 2017-08-22 | Janssen Pharmaceuticals. Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US10071095B2 (en) | 2009-05-12 | 2018-09-11 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders |
US10106542B2 (en) | 2013-06-04 | 2018-10-23 | Janssen Pharmaceutica Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US10584129B2 (en) | 2013-06-04 | 2020-03-10 | Janssen Pharmaceuticals Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US9708315B2 (en) | 2013-09-06 | 2017-07-18 | Janssen Pharmaceutica Nv | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06211798A (en) | Tetrahydroisoquinoline derivative and its production | |
JP2021509685A (en) | Process for preparing chrysaborol and its intermediates | |
JP2826646B2 (en) | 3-substituted-5-halogenopyridine derivatives | |
JP3101721B2 (en) | Method for producing aromatic fluorine compound | |
JPS6232753B2 (en) | ||
CN101747268B (en) | Method for synthesizing 4-substituted-3-bromo-2-quinolone | |
WO2004007418A1 (en) | A process for the preparation of 2-acetoxymethyl-4 halo-but-1-yl acetates | |
CN101747267B (en) | Method for synthesizing 4-substituted-3-chlorine-2-carbostyril | |
YAMATO | New Synthesis of 1-Benzyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline Derivatives | |
EP0842919A1 (en) | Process for the preparation of 3,4-dihydroxy-3-cyclobutene-1,2-dione | |
US4124759A (en) | Preparation of auranofin by O-acetylation | |
JP4055246B2 (en) | 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same | |
KR950001277B1 (en) | Process for the preparation of oxybenzene derivatives | |
JPH06199805A (en) | Production of @(3754/24)3-substituted phenyl)pyrazole derivative | |
JPH06211797A (en) | Tetrahydroisoquinoline derivative, its production and antifungal agent | |
JPS6241510B2 (en) | ||
JPH01117889A (en) | Intermediate for producing penicillanic 6'-aminopenicillanoyl oxymethyl 1, 1-dioxide | |
JPH06228103A (en) | New octahydroacridine derivative and its production | |
JPS5951941B2 (en) | carbostyril derivatives | |
JPS63250396A (en) | 3'-azido-3'-deoxythymidine derivative | |
RO133248A2 (en) | Bicyclo[2.2.1.]heptane amines protected at hydroxyl group | |
CN111848552A (en) | Preparation method and application of 3- (substituted phenyl) oxetane-3-carboxylic acid and intermediate thereof | |
JPH05247056A (en) | Indolocarbazole derivative | |
JPS5951534B2 (en) | Method for producing 2-amino-3-hydroxypyridine derivative | |
JPS61293979A (en) | Production of 3-substituted-2-formylthiophene compound |